Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...

A new discovery offers hope for Huntington’s disease. This discovery provides hope that a DNA repair process may help slow or ...

This week at AAAS, PNNL scientists and colleagues discuss phenomics, exposomics, and the factors that influence DNA ...

There are many molecules with therapeutic potential, but it can be a challenge to deliver them to the right places at the ...

At the cellular level, pieces of important genetic information, called small RNA, have the ability to introduce important ...

California-based nonprofit Arc Institute and Stanford University, in collaboration with NVIDIA, unveiled Evo 2 on Wednesday ...

To learn about the progress being made in the RNA therapeutics space, we spoke to CTO and Co-Founder of La Jolla Labs, Jeff ...

Spliceosomes help cells remove large chunks of non-coding genetic information—called introns—from the precursors of messenger ...

RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...

RNA splicing is a cellular process that is critical for gene expression. After genes are copied from DNA into messenger RNA, portions of the RNA that don't code for proteins, called introns, are cut ...

Maravai LifeSciences Inc., a provider of life science reagents and services to researchers and biotech innovators, has ...